Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30)

Multhoff, Gabriele ; Combs, Stephanie E. ; Seier, Sophie ; Stangl, Stefan ; Sievert, Wolfgang ; Shevtsov, Maxim ; Blankenstein, Christiane ; Hildebrandt, Martin ; Kokowski, Konrad ; Hautmann, Matthias ; Hautmann, Hubert ; Rödel, Claus ; Fietkau, Rainer ; Huber, Rudolf ; Haller, Bernhard ; Ertl, Christine ; Devecka, Michal ; Offner, Robert ; Ahrens, Norbert

---

Alternative links to fulltext:DOI

---

Details

Item type:	Article
Journal or Publication Title:	Cancer research
Publisher:	American Association for Cancer Research
Place of Publication:	PHILADELPHIA
Volume:	80
Number of Issue or Book Chapter:	16supp
Date:	August 2020
Institutions:	Medicine > Lehrstuhl für Klinische Chemie und Laboratoriumsmedizin Medicine > Lehrstuhl für Strahlentherapie
Identification Number:	Value Type 10.1158/1538-7445.AM2020-LB-076 DOI
Dewey Decimal Classification:	600 Technology > 610 Medical sciences Medicine
Status:	Published
Refereed:	Yes, this version has been refereed
Created at the University of Regensburg:	Partially
Item ID:	50865

Indexed in

Web of Science

Export bibliographical data

ASCII CitationAtomBibTeXData Cite XMLDataCite XML OAIDublin CoreDublin Core (LZV)EndNoteHTML CitationJSONJSON LDMETSMODSOPENAIREOpenAPCRDF+N-TriplesRDF+N3RDF+XMLReferReference ManagerSimple MetadataXMLopenCostxMetaDissPlus

---

---

Metadata last modified: 03 Nov 2021 06:36

Owner only: item control page

Altmetric

Altmetric

Altmetric

Alternative Statistics (altmetrics)

More literature (via CORE)

More literature (via CORE)

More literature (via CORE)

More literature (via CORE)